What Can You Expect at the Premier Peptide Forum in 2026?
The Industry Dedicated Forum Focused on Emerging Peptide-Based Therapeutics
The 3rd Peptide-Based Therapeutics Summit returns to unite a close peptide community dedicated to identifying, designing, synthesizing, and accelerating optimized peptide-based therapies addressing the biggest challenges in discovery and development to advance clinical and commercial progress.
With unparalleled networking opportunities with leading organisations from biotech, pharma, solution providers and academia, the new and refreshed 2026 program will allow for in -depth learning and connections to help you strategize your peptide therapeutic journey towards life-saving treatments.
Top Sessions for 2026:
The Infinite Loop: Machine Learning for Discovery, Delivery & Rapid Manufacturing of Potential Medicines
Professor Bradley Pentalute, MIT
Computational Detail of Drug Discovery & Platform Technology Development for Cyclic Peptide
Atsushi Matsuo, Chugai Pharmaceuticals
Breaking Barriers - Redefining Oral Peptide Drug Delivery
Sumit Arora, Johnson & Johnson
Integrating mRNA Display with Phage Display to Discover Helically Constrained Peptides
Justin Lawrie, Parabilis Medicines
Key Pharma Leaders Attending in 2026
Hear first-hand from pharma giants as they deep dive into their perspectives on the peptide industry and case studies from macrocyclic discoveries, peptide-drug conjugate developments and oral peptide delivery to unlock the next wave of peptide drugs.
Testimonials
I am deeply interested in the emergence of the latest computational and machine learning approaches and how they complement more conventional library led approaches in peptide design. I believe the Peptide Therapeutics Summit represents an ideal event where these different themes are brought together.
Chris Brown, A*STAR
The next frontier in peptide therapeutics lies in designing molecules that go beyond target activity — peptides that are both functional and orally available. The Peptide-Based Therapeutics Summit provides an invaluable platform to connect experts across disciplines and showcase how AI and computational innovation are helping us make this vision a reality.
Alan Nafiev, Receptor AI
Emerging technologies are shaping the field of peptide drug conjugates (PDCs). Learnings in a small focused meeting setting will enhance my organizations efforts to contribute to the development of novel PDC therapeutics.
David White, ProteinQure
Having participated in this summit since its inception, I have seen it evolve and continue to evolve into one of the most essential events for the global peptide community. It brings together the full spectrum of peptide innovation, from AI-driven discovery to formulation and CMC, where science and strategy align to accelerate translation. Each year offers sharper insights, new partnerships, and a clearer view of how peptide research is transforming modern therapeutics. For anyone committed to advancing peptide drug development, this summit has become an indispensable touchpoint for the field.
Charles Johannes, EPOC Scientific
Download the Full Event Guide
- Learn from 40+ Expert Speakers
- NEW Two-Track Agenda covering Drug Discovery and Formulation & CMC
- NEW Business Development & Investment Panel
- 4 Deep-Dive Workshops to choose from
- 25+ Data-Driven Case Studies to hear
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.